ClinicalTrials.Veeva

Menu

Ursodeoxycholic Acid (Udca) as a Local Drug Delivery Agent in the Treatment of Intra-bony Defects

S

SVS Institute of Dental Sciences

Status

Unknown

Conditions

Bone Regeneration

Treatments

Drug: Ursodeoxycholic acid gel

Study type

Interventional

Funder types

Other

Identifiers

NCT04937023
SVSIDS/PERIO/1/2020

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy of ursodeoxycholic acid as local drug delivery agent in intra- bony defect to achieve bone regeneration.

Full description

Experimental: Main treatment group the prepared UDCA gel will be injected using a syringe with blunt cannula into the defect site.

Comparator: In patients allocated to control group, placebo gel will be injected in to the defect site using a syringe with blunt cannula.

Enrollment

26 estimated patients

Sex

All

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Systemically healthy male and female patients of age>18 years with intrabony defects - two wall or three wall defects and probing pocket depths (PPD) of >3mm will be included

Exclusion criteria

  • Medically compromised patients, pregnant women, heavy smokers, and patients who underwent radiotherapy or chemotherapy will be excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

26 participants in 2 patient groups, including a placebo group

UDCA gel will be injected using a syringe with blunt cannula into the defect site
Experimental group
Description:
In the test group, the prepared UDCA gel will be injected using a syringe with blunt cannula into the two or three wall intra-bony defects with probing pocket depth ≥3mm after performing SRP.
Treatment:
Drug: Ursodeoxycholic acid gel
placebo gel will be injected in to the defect site using a syringe with blunt cannula.
Placebo Comparator group
Description:
In patients allocated to control group, placebo gel will be injected in to the defect site using a syringe with blunt cannula after scaling and root planing.
Treatment:
Drug: Ursodeoxycholic acid gel

Trial contacts and locations

1

Loading...

Central trial contact

R V Chandra, MDS;DNB;PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems